Skip to main content
    G

    GSK plc (GSK)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - GENERAL • NYSE

    $50.41
    -0.04 (-0.07%)

    Market Cap: $101.13B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    GSK plc (GSK) Financials: Revenue, Profit and Cash Flow

    Updated Oct 28, 2026. Financial statements from company filings, amounts in GBP.

    GSK reported revenue of GBP 32.67B for the fiscal year ended Dec 31, 2025, up 4.1% from the year before. That year, net income was GBP 5.72B with a net margin of 17.5%, operating cash flow was GBP 7.74B and free cash flow was GBP 6.39B. The quarter ended Sep 30, 2026 had revenue of GBP 8.82B and net income of GBP 1.53B.

    Revenue and Margins

    The operating margin was 24.3% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from GBP 27.89B, a compound annual rate of 1.8%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 202532.67B+4.1%72.4%24.3%17.5%
    Dec 202431.38B+3.5%71.2%12.8%8.2%
    Dec 202330.33B+3.4%71.8%22.2%16.2%
    Dec 202229.32B+18.7%67.4%21.9%51.0%
    Dec 202124.70B+1.4%66.9%17.6%17.8%
    Dec 202024.35B-27.8%67.4%24.6%23.6%
    Dec 201933.75B+9.5%64.9%20.6%13.8%
    Dec 201830.82B+2.1%66.8%17.8%11.8%
    Dec 201730.19B+8.2%65.7%13.5%5.1%
    Dec 201627.89BN/A66.7%9.3%3.3%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income rose 121.7% from the year before. In the quarter ended Sep 2026, net income fell 23.9% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue32.67B31.38B30.33B29.32B24.70B24.35B33.75B30.82B30.19B27.89B
    Cost of revenue9.02B9.05B8.56B9.55B8.16B7.93B11.86B10.24B10.34B9.29B
    Gross profit23.65B22.33B21.76B19.77B16.53B16.43B21.89B20.58B19.84B18.60B
    Research and development7.53B6.40B6.22B5.49B5.02B4.79B4.57B3.89B4.48B3.63B
    Operating income7.93B4.02B6.75B6.43B4.36B5.98B6.96B5.48B4.09B2.60B
    Net income5.72B2.58B4.93B14.96B4.38B5.75B4.64B3.62B1.53B912.00M
    EBITDA10.40B6.67B9.15B8.56B6.49B8.07B9.43B7.35B6.18B4.43B
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue8.82B8.41B7.63B8.62B8.55B7.99B7.52B8.12B8.01B7.88B7.36B8.05B
    Gross profit6.56B6.14B5.75B5.96B6.29B5.82B5.58B5.56B5.62B5.76B5.39B5.63B
    Operating income2.55B481.00M2.29B1.51B2.59B2.02B2.22B696.00M189.00M1.65B1.49B573.00M
    Net income1.53B435.00M1.74B636.00M2.01B1.44B1.62B414.00M-58.00M1.17B1.05B350.00M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of GBP 17.03B exceeded cash and equivalents by 13.63B.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets61.12B59.46B75.22B60.15B107.14B109.95B105.57B58.07B56.38B59.08B
    Current assets17.51B17.00B23.77B20.77B25.29B27.68B25.82B16.93B15.91B16.71B
    Cash and equivalents3.40B3.69B3.74B3.72B5.79B8.60B6.24B3.87B3.83B4.90B
    Total liabilities45.16B46.38B58.91B50.05B78.23B81.50B81.25B54.39B52.89B54.12B
    Short-term debt3.01B2.35B3.59B3.95B4.88B5.09B9.16B5.79B2.83B4.13B
    Long-term debt14.02B13.70B14.15B17.04B20.57B23.43B22.58B20.23B14.22B14.62B
    Shareholder equity16.38B13.67B17.01B10.60B20.39B19.94B15.11B3.78B3.49B4.96B
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets72.18B61.37B82.91B61.12B82.58B81.20B78.35B59.46B58.05B73.40B73.91B75.22B
    Total liabilities53.69B44.29B59.93B45.16B61.37B61.53B60.73B46.38B44.60B55.99B57.20B58.91B
    Cash and equivalents2.95B3.09B4.54B3.40B4.44B4.93B5.76B3.69B3.19B3.74B3.52B3.74B
    Shareholder equity18.88B17.54B23.54B16.38B21.74B20.27B18.27B13.67B14.01B18.17B17.48B17.01B
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 82.6% of operating cash flow. Dividends came to 40.1% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow7.74B6.55B6.77B7.40B7.95B8.44B8.02B8.42B6.92B6.50B
    Capital expenditures1.35B2.98B2.34B2.26B2.93B2.24B2.16B1.80B2.20B2.35B
    Free cash flow6.39B3.57B4.42B5.14B5.02B6.20B5.86B6.63B4.72B4.14B
    Dividends paid2.56B2.44B2.25B3.47B4.00B3.98B3.95B3.93B3.91B4.85B
    Investing cash flow-4.23B-1.23B-1.59B-8.77B-1.78B2.16B-5.35B-1.55B-1.44B-1.27B
    Financing cash flow-3.69B-4.73B-5.64B823.00M-7.59B-10.13B-1.84B-6.39B-6.38B-6.39B
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow2.79B2.54B1.14B2.04B3.03B2.10B1.15B2.33B2.15B1.11B1.19B3.62B
    Capital expenditures372.39M328.95M443.00M560.25M428.37M633.00M448.00M1.14B842.00M442.00M314.45M587.28M
    Free cash flow2.41B2.21B698.00M1.48B2.60B1.46B697.00M1.19B1.31B671.00M876.15M3.03B
    Last 12 quarters

    Frequently Asked Questions About GSK

    What is GSK's annual revenue?

    GSK reported revenue of GBP 32.67B for the fiscal year ended Dec 31, 2025.

    How fast is GSK's revenue growing?

    Revenue was up 4.1% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 3.7%.

    Is GSK profitable?

    Yes. GSK reported net income of GBP 5.72B for the fiscal year ended Dec 31, 2025, with a net margin of 17.5%.

    How much free cash flow does GSK generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of GBP 7.74B minus capital expenditures of GBP 1.35B produced free cash flow of GBP 6.39B.

    How much debt does GSK have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of GBP 14.02B, short-term debt of GBP 3.01B and cash and equivalents of GBP 3.40B.